High-Risk Implants Need Toughest FDA Review, Group Says

Law360, New York (April 19, 2013, 6:45 PM EDT) -- The group Consumers Union urged the U.S. Food and Drug Administration on Thursday to require all high-risk implantable medical devices, including metal-on-metal hip implants and surgical mesh, to undergo the agency's most stringent review process before hitting the market.

The request came in a letter to the agency in support of its January proposal to require makers of metal-on-metal hip implants to file a premarket approval application or a product development protocol, which are pathways to FDA approval for medical devices that pose the greatest risk...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.